Bloomberg View: A Pricey Weapon to Fight AIDS

New AIDS drug Truvada is worth it
Photograph by Justin Sullivan/Getty Images

Public health experts gained another weapon in their battle against AIDS when the U.S. Food and Drug Administration approved an HIV drug for preventive use. This will help pave the way for its authorization in developing countries. The drug, called Truvada, is expensive, but it could do considerable good in Africa if deployed smartly.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.